Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Clinical trial NCT03779854 · RECRUITING

Trial details

NCT number: NCT03779854
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Biphenotypic Leukemia Acute Leukemia Acute Leukemia of Ambiguous Lineage Acute Lymphoblastic Leukemia Acute Undifferentiated Leukemia Allogeneic Hematopoietic Stem Cell Transplantation Recipient Blastic Plasmacytoid Dendritic Cell Neoplasm Blasts Under 25 Percent of Bone Marrow Nucleated Cells Blasts Under 5 Percent of Bone Marrow Nucleated Cells Mixed Phenotype Acute Leukemia Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome/Acute Myeloid Leukemia

Start date: 2019-08-29
Primary completion: 2028-12-31
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.